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Improving Acute Pain Management:  
Development of an Adult Dexmedetomidine Infusion Protocol 
Tim Denney, BSN, RN 
Introduction of the Problem 
 Studies have revealed over 80% of surgical patients experience acute 
postoperative pain: 75% of patients describe pain levels as moderate, severe, or extreme 
(Chou et al., 2016).  Unfortunately, for the 25 million inpatient surgical procedures 
performed each year throughout the United States, opioids continue to be the mainstay of 
most postoperative analgesia regimens (Tan, Law, & Gan, 2015).  While effective for the 
treatment of severe pain, opioid use also prolongs length of hospital stay and places 
patients at greater risk for higher adjusted mean costs due to dose-related side effects, 
such as respiratory depression, excessive sedation, postoperative nausea and vomiting, 
urinary retention, and ileus (Tan et al., 2015). Moreover, opioid consumption 
subsequently leads to rapid development of tolerance and a reduction in pain threshold 
(i.e. opioid-induced hyperalgesia), which makes effective pain management during the 
perioperative period difficult to achieve (Tan et al., 2015). Multimodal analgesia is a 
concept that continues to gain momentum to improve perioperative analgesia while 
reducing the incidence of opioid-related adverse events (Buvanendran & Kroin, 2009).  
Therefore, the purpose of this project was to improve acute pain management, 
particularly for opioid-tolerant patients, in the perioperative setting through the 
development of an adult dexmedetomidine infusion protocol for a tertiary care center in 
central Illinois.  Dexmedetomidine was being under-utilized at the tertiary care center, 
and an adult dexmedetomidine infusion protocol was not in place, thus, providing clinical 
relevance for this project. 
Literature Review 
 Evidence-based research has indicated the use of dexmedetomidine in the 
perioperative setting as a successful adjunct to a multimodal pain management regimen 
(Chou et al., 2016; Tan et al., 2015).  Research confirmed the ability of dexmedetomidine 
to minimize total opioid consumption and opioid-related adverse effects while 
maintaining appropriate pain scores (Blaudszun et al., 2012; Le Bot et al., 2015; Lundorf 
et al., 2016; Peng, et al., 2015; Schnabel et al., 2013; Shenhui et al., 2017).  Literature 
suggested the value of dexmedetomidine as part of a multimodal pain management 
regimen for opioid tolerant patients and to help prevent the development of OIH (Chu et 
al., 2008).  As demonstrated in the multitude of research studies, dexmedetomidine can 
be administered as a bolus, a continuous low-dose infusion, alongside an opioid-based 
PCA, or a combination of these methods at various times throughout the perioperative 
period.  Research also presented a wide range of dosing regimens for dexmedetomidine 
(Blaudszun et al., 2012; Le Bot et al., 2015; Lundorf et al., 2016; Peng, et al., 2015; 
Schnabel et al., 2013; Shenhui et al., 2017).  Bolus doses ranged from 0.1-2 mcg/kg, with 
the most common bolus dose being 0.5 mcg/kg or 1 mcg/kg.  Continuous low-dose 
infusion rates ranged from 0.1-1 mcg/kg/hr, with the most common infusion range being 
approximately 0.2-0.7 mcg/kg/hr.  Further research is needed for determination of the 
optimal dosing regimen of dexmedetomidine and the timing of administration within the 
perioperative period. 
 
Project Methods 
This project utilized a non-experimental design to assist in the creation and 
introduction of an evidence-based adult dexmedetomidine infusion protocol for a tertiary 
care center in central Illinois. The purpose of this project was to increase awareness and 
knowledge among the key stakeholders concerning the use of dexmedetomidine as part of 
a multimodal approach to treat pain in the perioperative setting, particularly for opioid-
tolerant patients.  Using the evidence within the extensive literature review, the proposed 
protocol provided anesthesia providers with research-based practice for employing 
multimodal analgesia to treat perioperative pain, particularly in opioid-tolerant patients.  
The project was implemented at a tertiary care center in central Illinois.  A large 
group of staff members attended the educational presentation, and staff members electing 
to participate in the project completed a post-presentation survey.  The survey included 
demographic information, true/false questions related to information provided during the 
educational presentation, a Likert scale to assess staff support for the implementation of 
an adult perioperative dexmedetomidine infusion protocol, and a section for open-ended 
comments. 
This project was declared exempt from the Southern Illinois University 
Edwardsville Institutional Review Board and was approved by the Research Review 
Committee at the tertiary care center.  The project was a quality improvement design and 
did not include patient information or direct patient interaction.  Also, this project posed 
minimal risks, such as time inconvenience, to those who completed the survey. 
Participation in the survey was voluntary.  
 
Evaluation 
 Results from the implementation of the verbal educational presentation indicated 
increased knowledge for staff members related to the perioperative use of 
dexmedetomidine for acute pain management, particularly in opioid-tolerant patients.  
From all of the staff members attending the educational presentation, 15 participants 
completed the post-presentation survey used to analyze results. All survey participants 
recognized that 80% of surgical patients experience acute postoperative pain, and the 
proportion of opioid-tolerant patients requiring acute pain management has significantly 
increased. Furthermore, all participants were able to identify the goals of multimodal 
analgesia and demonstrated the understanding that multimodal analgesia is the preferred 
approach for the treatment of postoperative pain in children and adults.  Nearly all 
participants (93%) correctly identified dexmedetomidine as a highly selective alpha-2 
receptor agonist with sedative, anxiolytic, sympatholytic, and analgesic-sparing 
properties.  All participants recognized the ability of dexmedetomidine to decrease total 
postoperative opioid consumption and opioid-related side effects while maintaining 
sufficient analgesia when added to a multimodal regimen. Less than a majority of the 
participants (40%) understood the inability of dexmedetomidine to provide an adequate 
level of analgesia when administered alone.  Prior to the presentation, a small percentage 
of participants (13%) routinely administered dexmedetomidine as an adjunct to acute 
pain management in opioid tolerant patients. 
 A 5-point Likert Scale was included in the survey to assess support by the staff 
members regarding the implementation of an adult perioperative dexmedetomidine 
infusion protocol. The mean score was 4.29, which suggested strong staff member 
support for the implementation of an adult perioperative dexmedetomidine infusion 
protocol. 
 The greatest limitation to this project was the nonexperimental design, because 
the dexmedetomidine infusion protocol was developed from an extensive literature 
review and not from experimental research on human subjects. Therefore, the success of 
this project greatly depends on the acceptance and implementation of the protocol into 
daily practice by the anesthesia and pharmacy departments at the tertiary care center in 
central Illinois.  Other limitations to this project include sampling bias and a limited 
sample size.  Due to time constraints and staff member availability, a convenience sample 
was used for this project.  Only 15 staff members properly completed the post-
presentation survey. Thus, the results from this project are not generalizable due to the 
small sample size. 
         Impact on Practice 
 The purpose of this doctoral project was to improve acute pain management, 
particularly for opioid-tolerant patients, in the perioperative setting through the 
development of an adult dexmedetomidine infusion protocol for a tertiary care center in 
central Illinois.  Specific project objectives included an extensive literature review to 
determine the usefulness of dexmedetomidine for perioperative pain management and to 
develop an adult dexmedetomidine infusion protocol based on evidence reported in the 
literature that demonstrated best outcomes.  According to survey results, a small number 
of anesthesia providers previously used dexmedetomidine as an adjunct to acute pain 
management in opioid tolerant patients.  However, results indicated the educational 
presentation increased staff knowledge regarding the use of dexmedetomidine as part of a 
multimodal pain management regimen in the perioperative setting. Furthermore, 
according to the 5-point Likert scale, staff members favored the implementation of an 
adult perioperative dexmedetomidine infusion protocol.  The date of implementation for 
the dexmedetomidine infusion protocol at the tertiary care center remains undetermined.  
Conclusion 
Multimodal analgesia has proven to be an effective approach to improving 
perioperative analgesia.  The primary benefits of such an approach is a reduction in total 
opioid consumption, which minimizes potential adverse side effects and expedites the 
recovery process.  Evidence-based research has verified the ability of dexmedetomidine 
to decrease total opioid consumption and opioid-related adverse effects while maintaining 
appropriate pain scores when part of a multimodal regimen (Tan et al., 2015).  
Additionally, literature has supported the use of dexmedetomidine as a successful adjunct 
to a multimodal pain management regimen for opioid-tolerant patients.  Therefore, this 
project aimed to provide education to the anesthesia and pharmacy departments at a 
tertiary care center in central Illinois concerning the use of a dexmedetomidine infusion 
protocol as part of a multimodal pain management regimen, particularly for opioid-
tolerant patients. The results of the project suggested the anesthesia providers at the 
facility increased their knowledge pertaining to the use of the dexmedetomidine and 
supported the implementation of a dexmedetomidine infusion protocol. 
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